Becton, Dickinson and Co. | BDX - Loan Capital

Stock Price
149.52
Daily Change
-0.70 -0.47%
Monthly
-3.34%
Yearly
-27.57%
Q2 Forecast
148.88

Becton, Dickinson and Co. reported $16.92B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Agilent USD 3.05B 0 Dec/2025
Align Technology USD 0 0 Dec/2024
AngioDynamics USD 5.6M 100K Sep/2025
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
Boston Scientific USD 11.01B 19M Dec/2025
Cooper Companies USD 1.88B 578.5M Dec/2025
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.02B 2M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 600M 1.7M Mar/2026
Globus Medical USD 436K 9K Dec/2025
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.53B 1.91B Mar/2026
Masimo USD 518M 41.1M Dec/2025
Medtronic USD 27.88B 255M Dec/2025
Solventum Corp USD 5.04B 102M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
Terumo JPY 99.9B 12M Dec/2025
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026